138 related articles for article (PubMed ID: 26117184)
1. Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin.
Yuan ZX; Wu XJ; Mo J; Wang YL; Xu CQ; Lim LY
Eur J Pharm Biopharm; 2015 Aug; 94():363-71. PubMed ID: 26117184
[TBL] [Abstract][Full Text] [Related]
2. Peptide fragments of human serum albumin as novel renal targeting carriers.
Yuan ZX; He XK; Wu XJ; Gao Y; Fan M; Song LQ; Xu CQ
Int J Pharm; 2014 Jan; 460(1-2):196-204. PubMed ID: 24184033
[TBL] [Abstract][Full Text] [Related]
3. Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes.
Yuan ZX; Jia L; Lim LY; Lin JC; Shu G; Zhao L; Ye G; Liang XX; Ji H; Fu HL
Int J Nanomedicine; 2017; 12():5673-5686. PubMed ID: 28848346
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide.
Zheng Q; Gong T; Sun X; Zhang ZR
Arch Pharm Res; 2006 Dec; 29(12):1164-70. PubMed ID: 17225468
[TBL] [Abstract][Full Text] [Related]
5. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.
Mei Z; Li X; Wu Q; Hu S; Yang X
Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748
[TBL] [Abstract][Full Text] [Related]
6. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model.
Chen JG; Liu YF; Gao TW
J Liposome Res; 2010 Dec; 20(4):297-303. PubMed ID: 20102297
[TBL] [Abstract][Full Text] [Related]
7. Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents.
Xu L; Qiu Y; Xu H; Ao W; Lam W; Yang X
Food Chem Toxicol; 2013 Jul; 57():371-9. PubMed ID: 23583804
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
[TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation.
He QL; Minn I; Wang Q; Xu P; Head SA; Datan E; Yu B; Pomper MG; Liu JO
Angew Chem Int Ed Engl; 2016 Sep; 55(39):12035-9. PubMed ID: 27574181
[TBL] [Abstract][Full Text] [Related]
10. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis.
Zhang W; Lu C; Liu Z; Yang D; Chen S; Cha A; Wu Z; Lu A
Planta Med; 2007 Apr; 73(4):336-40. PubMed ID: 17354165
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide.
Tian T; Song Y; Li K; Sun Y; Wang Q
Mol Pharm; 2018 Feb; 15(2):560-570. PubMed ID: 29307194
[TBL] [Abstract][Full Text] [Related]
13. Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity.
Ren Q; Li M; Deng Y; Lu A; Lu J
Pharmacol Res; 2021 Mar; 165():105377. PubMed ID: 33484817
[TBL] [Abstract][Full Text] [Related]
14. Effect of poly(D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysis.
Liu M; Dong J; Yang Y; Yang X; Xu H
J Nanosci Nanotechnol; 2008 Jul; 8(7):3493-9. PubMed ID: 19051901
[TBL] [Abstract][Full Text] [Related]
15. Triptolide-targeted delivery methods.
Xu H; Liu B
Eur J Med Chem; 2019 Feb; 164():342-351. PubMed ID: 30605832
[TBL] [Abstract][Full Text] [Related]
16. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity.
Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y
Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922
[TBL] [Abstract][Full Text] [Related]
17. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide.
Qu L; Qu F; Jia Z; Wang C; Wu C; Zhang J
J Ethnopharmacol; 2015 Jul; 170():28-38. PubMed ID: 25978956
[TBL] [Abstract][Full Text] [Related]
18. Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4.
Zheng N; Wei A; Wu T; Long L; Yang H; Li H; Wang L
Toxicol Lett; 2021 May; 342():85-94. PubMed ID: 33600922
[TBL] [Abstract][Full Text] [Related]
19. Kinetic release of triptolide after injection of renal-targeting 14-succinyl triptolide-lysozyme in a rat kidney study by liquid chromatography/mass spectrometry.
Zheng Q; Ye L; Gao R; Han J; Xiong M; Zhao D; Gong T; Zhang Z
Biomed Chromatogr; 2007 Jul; 21(7):724-9. PubMed ID: 17370252
[TBL] [Abstract][Full Text] [Related]
20. The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells.
Zhang Z; Zheng Q; Han J; Gao G; Liu J; Gong T; Gu Z; Huang Y; Sun X; He Q
Biomaterials; 2009 Mar; 30(7):1372-81. PubMed ID: 19100618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
